MedCognition has received a broad system and method patent from the U.S. Patent and Trademark office for its extended reality (XR)-based training technology. U.S. Patent No. 12,210,668 B2 covers systems and methods to improve patient outcomes through hyper-realistic educational simulations.

Integrated within the company’s PerSim medical education and training platform, the patented XR-based technology increases training efficacy by providing a safe and controlled environment that closely resembles authentic patient encounters, allowing students to refine their clinical skills and improve preparedness through real-world scenario simulations.

“This patent represents a significant milestone for MedCognition and highlights our commitment to developing innovative technologies that transform the way healthcare professionals learn and practice,” MedCognition CEO Russell J. Unrath said. “Our XR-based simulation provides learners with unparalleled opportunities for hands-on experience, empowering them to deliver high-quality patient care.”

Designed to streamline medical training while fostering greater understanding and retention of critical procedures, the patented methods simulate a wide range of patient presentations and allow educators to customize learning experiences to meet diverse training needs.

MedCognition is a San Antonio, Texas-based medical technology company that provides medical training simulations to advance healthcare education and improve patient outcomes. With a focus on immersive learning experiences, MedCognition empowers medical professionals to excel in their training and save lives.

The company’s augmented reality training platform, PerSim, is a first-of-its-kind patient simulator specifically designed to help medical providers enhance critical thinking and mitigate potential mistakes. By leveraging the latest in augmented reality and holographic technology, PerSim represents a leap forward in realism, portability, and affordability, allowing medical professionals to train for critical times.